MESSINA, ROBERTA
 Distribuzione geografica
Continente #
EU - Europa 1.713
AS - Asia 1.541
NA - Nord America 1.321
SA - Sud America 377
AF - Africa 30
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.987
Nazione #
US - Stati Uniti d'America 1.258
RU - Federazione Russa 1.113
SG - Singapore 557
CN - Cina 505
BR - Brasile 308
HK - Hong Kong 186
IT - Italia 180
VN - Vietnam 159
SE - Svezia 138
FR - Francia 68
DE - Germania 57
GB - Regno Unito 36
AR - Argentina 31
CA - Canada 29
MX - Messico 29
IN - India 25
FI - Finlandia 21
IE - Irlanda 18
PL - Polonia 18
BD - Bangladesh 16
ES - Italia 15
EC - Ecuador 12
ID - Indonesia 12
TR - Turchia 12
JP - Giappone 10
CO - Colombia 9
ZA - Sudafrica 9
AT - Austria 8
IQ - Iraq 8
NL - Olanda 8
UA - Ucraina 8
JO - Giordania 7
LT - Lituania 7
CL - Cile 6
SA - Arabia Saudita 6
TW - Taiwan 5
AU - Australia 4
DK - Danimarca 4
PK - Pakistan 4
UZ - Uzbekistan 4
CH - Svizzera 3
KE - Kenya 3
KR - Corea 3
KZ - Kazakistan 3
MA - Marocco 3
NO - Norvegia 3
PE - Perù 3
PY - Paraguay 3
TN - Tunisia 3
ZW - Zimbabwe 3
BE - Belgio 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
KW - Kuwait 2
MY - Malesia 2
NG - Nigeria 2
NP - Nepal 2
OM - Oman 2
PH - Filippine 2
PT - Portogallo 2
UY - Uruguay 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BG - Bulgaria 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
LB - Libano 1
MK - Macedonia 1
MW - Malawi 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 4.987
Città #
Dallas 394
Singapore 297
Moscow 212
Hong Kong 183
Ashburn 172
San Jose 94
Shanghai 92
Hefei 72
Ho Chi Minh City 57
Lauterbourg 56
New York 56
Milan 52
Beijing 44
São Paulo 41
Lawrence 38
Princeton 38
Los Angeles 37
Munich 25
Council Bluffs 24
Hanoi 23
Boardman 21
Rome 21
Orem 20
Dublin 18
Denver 17
Warsaw 17
Santa Clara 15
Montreal 14
Chennai 12
Guangzhou 12
Nuremberg 12
Stockholm 11
Atlanta 10
Biên Hòa 10
Curitiba 10
Helsinki 9
Houston 9
Manchester 9
Tokyo 9
Chicago 8
Mexico City 8
Poplar 8
Seattle 8
Tianjin 8
Amman 7
Ankara 7
Florence 7
Haiphong 7
Phoenix 7
Turku 7
Brasília 6
Brooklyn 6
Da Nang 6
Hải Dương 6
Johannesburg 6
Querétaro 6
Turin 6
Belo Horizonte 5
Bergamo 5
Betim 5
Bogotá 5
Lappeenranta 5
London 5
Porto Alegre 5
Quito 5
Recife 5
Rho 5
Ribeirão das Neves 5
Rio de Janeiro 5
Amsterdam 4
Baghdad 4
Boston 4
Charlotte 4
Falkenstein 4
Marostica 4
Olímpia 4
Passo Fundo 4
Pisa 4
San Francisco 4
Shenzhen 4
St Petersburg 4
Tashkent 4
Vienna 4
Washington 4
Bologna 3
Buenos Aires 3
Buffalo 3
Camarillo 3
Cesano Boscone 3
Cincinnati 3
Coimbatore 3
Copenhagen 3
Genoa 3
Guayaquil 3
Ha Long 3
Hackney 3
Hangzhou 3
Harare 3
Indianapolis 3
Jacareí 3
Totale 2.555
Nome #
A novel scoring approach to identify responders to erenumab in clinical practice 181
Resting State Functional Connectivity Changes of the Pons in Migraine Patients: A Cross-Sectional and Longitudinal Study 170
Alterations of brain structural MRI are associated with outcome of surgical treatment in trigeminal neuralgia 161
A 24-week prospective, multicenter, real-world study on eptinezumab’s effectiveness and safety in migraine prevention (EMBRACE II) 116
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response 112
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN) 108
Imaging the brain and vascular reactions to headache treatments: a systematic review 104
Comparison of efficacy and safety of erenumab between over and under 65-year-old refractory migraine patients: a pivotal study 98
Brain connectivity abnormalities extend beyond the sensorimotor network in peripheral neuropathy 98
Efficacy and safety of anti-CGRP monoclonal antibodies for chronic migraine prophylaxis in patients treated with botulinum toxin A: A prospective monocentric study 96
Tension-type headache 93
An update on migraine: current understanding and future directions 91
Clinical correlates of hypothalamic functional changes in migraine patients 89
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients 87
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience 86
Extent and characteristics of carotid plaques and brain parenchymal loss in asymptomatic patients with no indication for revascularization 84
Stress in paediatric migraine: a trigger factor? 84
Myocardial infarction in a patient with migraine and triptan overuse treated with anti-CGRP receptor monoclonal antibody: a case report 83
Candesartan in migraine prevention: results from a retrospective real-world study 83
Biomarkers of Migraine and Cluster Headache: Differences and Similarities 80
Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real‐life study 80
Tracking the evolution of non-headache symptoms through the migraine attack 79
CGRP – a target for acute therapy in migraine: Clinical data 79
Cortical abnormalities in patients with migraine: a surface-based analysis. 74
Functional MRI in migraine 73
DIFFERENCES IN BRAIN STRUCTURE AND FUNCTION IN PRIMARY HEADACHE DISORDERS: A MULTIMODAL MRI STUDY 73
Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study 72
Imaging of Migraine and Vestibular Migraine 71
Erenumab effect on brain network function in episodic migraine patients: a randomized, placebo-controlled, clinical trial 70
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study 70
Evaluating the Effectiveness, Tolerability, and Safety of Eptinezumab in High-Frequency and Chronic Migraine in Real World: EMBRACE—The First Italian Multicenter, Prospective, Real-Life Study 68
Long-term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study 67
A review of recent literature on functional MRI and personal experience in two cases of definite vestibular migraine 66
Cervical Cord T1-weighted Hypointense Lesions at MR Imaging in Multiple Sclerosis: Relationship to Cord Atrophy and Disability 66
Brain structural and functional abnormalities in Fahr's disease: a report of two cases 65
Neural correlates of visuospatial processing in migraine: does the pain network help? 63
A novel scoring approach to identify responders to erenumab in clinical practice 62
Insights into migraine attacks from neuroimaging 61
An Altered Hypothalamic-Pontine Functional Interplay Could Affect Migraine Disease Progression Over the Years 61
Influence of the topography of brain damage on depression and fatigue in patients with multiple sclerosis. 61
Dysregulation of multisensory processing stands out from an early stage of migraine: a study in pediatric patients 57
Relation between characteristics of carotid atherosclerotic plaques and brain white matter hyperintensities in asymptomatic patients 56
Three-year treatment with anti-CGRP monoclonal antibodies modifies migraine course: the prospective, multicenter I-GRAINE study 55
What imaging has revealed about migraine and chronic migraine 54
Regional cervical cord atrophy and disability in multiple sclerosis: a voxel-based analysis. 54
The Chronic Migraine Brain: What Have We Learned From Neuroimaging? 54
Editorial: Functional and Structural Brain Alterations in Headache: A Trait or a State? 54
Unveiling Functional and Structural Brain MRI Alterations in Opioid Use Disorder 53
Author response: Gray matter volume modifications in migraine: A cross-sectional and longitudinal study 53
Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE) 52
Structural brain abnormalities in patients with vestibular migraine 51
Pathophysiological Bases of Comorbidity in Migraine 50
Recent advances in headache neuroimaging 49
What We Gain From Machine Learning Studies in Headache Patients 49
Gray matter volume modifications in migraine: A cross-sectional and longitudinal study 48
Refractory chronic migraine: is drug withdrawal necessary before starting a therapy with onabotulinum toxin type A? 47
White matter microstructure abnormalities in pediatric migraine patients 46
Distributed abnormalities of brain white matter architecture in patients with dominant optic atrophy and OPA1 mutations 45
Editorial: Still Searching for the Origin of Migraine: From Comorbidities to Chronicization 43
Multiple sclerosis imaging: recent advances. 43
Imaging the migrainous brain: the present and the future 43
Resting-state fMRI functional connectivity: a new perspective to evaluate pain modulation in migraine? 42
Estimating brain lesion volume change in multiple sclerosis by subtraction of magnetic resonance images 39
fMRI of the sensorimotor system 39
Imaging of migraine and vestibular migraine 39
Structural brain MRI abnormalities in pediatric patients with migraine 38
fMRI of pain 38
Biomarkers of treatment response 35
Exploring the role of the pons and hypothalamus in migraine disease progression 34
Resting State Functional Connectivity Changes of the Hypothalamus in Migraine Patients: A Cross-Sectional and Longitudinal Study 33
Neural Correlates of Visuospatial Processing in Migraine Patients: Does the Pain Network Interfere? 33
Neural correlates of visuospatial processing in migraine patients: does the pain network interfere? 32
Resting State Functional Connectivity Changes of the Hypothalamus in Migraine Patients: A Cross-Sectional and Longitudinal Study 31
MRI studies can predict progression of disease years before it occurs 30
Neural correlates of visuospatial processing in migraine patients: does the pain network interfere? 28
RESTING STATE FUNCTIONAL CONNECTIVITY CHANGES OF THE HYPOTHALAMUS IN MIGRAINE PATIENTS: A CROSS-SECTIONAL AND LONGITUDINAL STUDY 26
Migraine treatments: what have we learned from neuroimaging? 23
Super- and absolute responders to anti-cgrp monoclonal antibodies in migraine: A one-year multicenter, prospective, observational study 20
Insights into Migraine Treatments. Towards Personalized Medicine 20
Unveiling Resting-State Functional Connectivity Patterns in Patients With Migraine: A REFORM Study 8
Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis 4
Health equity, care access and quality in headache – part 2 3
Exploring the role of the pons and hypothalamus in migraine progression 2
Combining treatments for migraine prophylaxis: the state-of-the-art 2
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials 2
Exploring the role of the pons and hypothalamus in migraine progression 2
Influence of next-generation artificial intelligence on headache research, diagnosis and treatment: the junior editorial board members’ vision – part 1 2
Worldwide availability of medications for migraine and tension-type headache: A survey of the International Headache Society 2
Interventions for Migraine and Sleep: A Systematic Review Exploring Their Bidirectional Association 1
Totale 5.149
Categoria #
all - tutte 25.821
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.821


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 0 2 0
2021/202234 0 1 1 11 0 4 5 2 1 1 6 2
2022/2023255 88 50 26 1 7 29 15 18 7 1 7 6
2023/2024258 6 11 31 22 41 36 8 32 7 9 16 39
2024/2025925 95 23 28 23 44 85 77 91 141 154 71 93
2025/20263.642 258 312 419 511 270 147 283 274 1.035 133 0 0
Totale 5.149